His lab is working on refining the alanine-scanning assay to a few critical residues that will properly distinguish among fibrils from neurodegenerative tauopathies. He envisions making use of this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.To Jubao Duan from the University of Chicago,